|
IL105325A
(en)
*
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
EP0688205A1
(en)
*
|
1993-03-11 |
1995-12-27 |
Secretech, Inc. |
Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces
|
|
WO1995011700A1
(en)
*
|
1993-10-29 |
1995-05-04 |
Pharmos Corp. |
Submicron emulsions as vaccine adjuvants
|
|
US5961970A
(en)
*
|
1993-10-29 |
1999-10-05 |
Pharmos Corporation |
Submicron emulsions as vaccine adjuvants
|
|
GB9417742D0
(en)
*
|
1994-09-03 |
1994-10-19 |
Univ Nottingham |
Macrophage stimulating composition
|
|
BE1008977A5
(fr)
*
|
1994-12-27 |
1996-10-01 |
Solvay |
Adjuvants pour vaccins.
|
|
US5891393A
(en)
*
|
1996-04-09 |
1999-04-06 |
The University Of North Carolina At Chapel Hill |
Method for the microbial decontamination of blood platelets
|
|
GB9622159D0
(en)
*
|
1996-10-24 |
1996-12-18 |
Solvay Sociutu Anonyme |
Polyanionic polymers as adjuvants for mucosal immunization
|
|
US6197327B1
(en)
*
|
1997-06-11 |
2001-03-06 |
Umd, Inc. |
Device and method for treatment of dysmenorrhea
|
|
US6416779B1
(en)
|
1997-06-11 |
2002-07-09 |
Umd, Inc. |
Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
|
|
US6572874B1
(en)
|
1998-05-15 |
2003-06-03 |
Umd, Inc. |
Vaginal delivery of bisphosphonates
|
|
FR2775601B1
(fr)
*
|
1998-03-03 |
2001-09-21 |
Merial Sas |
Vaccins vivants recombines et adjuves
|
|
FR2776928B1
(fr)
|
1998-04-03 |
2000-06-23 |
Merial Sas |
Vaccins adn adjuves
|
|
JP5124066B2
(ja)
*
|
1999-03-24 |
2013-01-23 |
イギリス国 |
ポリカチオン性炭水化物のワクチンにおける免疫賦活剤としての使用
|
|
US6943152B1
(en)
*
|
1999-06-10 |
2005-09-13 |
Merial |
DNA vaccine-PCV
|
|
US7018638B2
(en)
|
2000-12-19 |
2006-03-28 |
Wyeth |
Mycoplasma hyopneumoniae bacterin vaccine
|
|
MY129765A
(en)
|
2000-12-19 |
2007-04-30 |
Wyeth Corp |
Improved mycoplasma hyopneumoniae bacterin vaccine
|
|
US6676958B2
(en)
*
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
|
CA2513655C
(en)
|
2003-01-21 |
2011-11-22 |
Chiron Corporation |
Use of tryptanthrin compounds for immune potentiation
|
|
WO2004087153A2
(en)
|
2003-03-28 |
2004-10-14 |
Chiron Corporation |
Use of organic compounds for immunopotentiation
|
|
WO2006115509A2
(en)
|
2004-06-24 |
2006-11-02 |
Novartis Vaccines And Diagnostics Inc. |
Small molecule immunopotentiators and assays for their detection
|
|
WO2006002422A2
(en)
|
2004-06-24 |
2006-01-05 |
Novartis Vaccines And Diagnostics Inc. |
Compounds for immunopotentiation
|
|
UA95602C2
(ru)
|
2004-12-30 |
2011-08-25 |
Берингер Ингельхейм Ветмедика, Инк. |
Иммуногенная композиция цвс2 и способы приготовления такой композиции
|
|
WO2007079147A2
(en)
|
2005-12-28 |
2007-07-12 |
Advanced Bionutrition Corporation |
A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
|
MX338626B
(es)
|
2005-12-29 |
2016-04-26 |
Boehringer Ingelheim Vetmed |
Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
|
|
EP1968630B1
(en)
|
2005-12-29 |
2018-01-24 |
Boehringer Ingelheim Vetmedica, Inc. |
Multivalent pcv2 immunogenic compositions
|
|
ES2536426T3
(es)
*
|
2006-03-23 |
2015-05-25 |
Novartis Ag |
Compuestos de imidazoquinoxalina como inmunomoduladores
|
|
US8063063B2
(en)
*
|
2006-03-23 |
2011-11-22 |
Novartis Ag |
Immunopotentiating compounds
|
|
EP2010530A2
(en)
*
|
2006-03-23 |
2009-01-07 |
Novartis AG |
Methods for the preparation of imidazole-containing compounds
|
|
EP2859900A1
(en)
|
2006-12-11 |
2015-04-15 |
Boehringer Ingelheim Vetmedica, Inc. |
Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
|
|
EP1941903A1
(en)
|
2007-01-03 |
2008-07-09 |
Boehringer Ingelheim Vetmedica Gmbh |
Prophylaxis and treatment of PRDC
|
|
EP1958644A1
(en)
|
2007-02-13 |
2008-08-20 |
Boehringer Ingelheim Vetmedica Gmbh |
Prevention and treatment of sub-clinical pcvd
|
|
US20080292663A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Gerber Jay D |
Adjuvant compositions and methods for delivering vaccines
|
|
KR20100113582A
(ko)
|
2008-01-23 |
2010-10-21 |
베링거잉겔하임베트메디카인코퍼레이티드 |
Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
|
|
RS53347B
(sr)
|
2008-12-09 |
2014-10-31 |
Gilead Sciences, Inc. |
Modulatori toll-sličnih receptora
|
|
WO2010114169A1
(en)
*
|
2009-03-31 |
2010-10-07 |
Japan As Represented By The Director-General Of National Institute Of Infectious Diseases |
Method for prophylaxis of influenza using vaccine for intranasal administration
|
|
EP2435554B1
(en)
|
2009-05-26 |
2017-07-26 |
Advanced Bionutrition Corporation |
Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
|
|
PL2529004T3
(pl)
|
2010-01-28 |
2017-12-29 |
Advanced Bionutrition Corporation |
Sucha szklista kompozycja zawierająca bioaktywny materiał
|
|
US9504750B2
(en)
|
2010-01-28 |
2016-11-29 |
Advanced Bionutrition Corporation |
Stabilizing composition for biological materials
|
|
EP4218808A3
(en)
|
2012-03-12 |
2023-08-09 |
Advanced BioAdjuvants, LLC |
Adjuvant and vaccine compositions
|
|
UA114503C2
(uk)
|
2012-04-04 |
2017-06-26 |
Зоетіс Сервісіз Ллс |
Комбінована вакцина pcv та mycoplasma hyopneumoniae
|
|
UA114504C2
(uk)
|
2012-04-04 |
2017-06-26 |
Зоетіс Сервісіз Ллс |
Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
|
|
US9120859B2
(en)
|
2012-04-04 |
2015-09-01 |
Zoetis Services Llc |
Mycoplasma hyopneumoniae vaccine
|
|
US9505808B2
(en)
|
2013-10-02 |
2016-11-29 |
Boehringer Ingelheim Vetmedica, Inc. |
PCV2 ORF2 protein variant and virus like particles composed thereof
|
|
WO2016001907A1
(en)
|
2014-07-02 |
2016-01-07 |
Prendergast Patrick T |
Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
|
|
US12558395B2
(en)
|
2015-07-29 |
2026-02-24 |
Advanced Bionutrition Corp. |
Stable dry probiotic compositions for special dietary uses
|
|
MY194231A
(en)
|
2015-07-29 |
2022-11-23 |
Advanced Bionutrition Corp |
Stable dry probiotic compositions for special dietary uses
|
|
EP3801628A1
(en)
|
2018-06-04 |
2021-04-14 |
Apros Therapeutics, Inc. |
Tlr7 peptide conjugates
|
|
KR20210027381A
(ko)
|
2018-07-02 |
2021-03-10 |
아유비스 리서치, 인코포레이티드 |
신규 면역조절 소분자
|